Immediate Impact
4 from Science/Nature 52 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of Robert Schulingkamp being referenced
A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Robert Schulingkamp | 229 | 32 | 10 | 155 | 147 | 14 | 589 | |
| José Marques-Lopes | 292 | 8 | 2 | 179 | 125 | 20 | 668 | |
| Magda M. Santana | 243 | 27 | 111 | 212 | 16 | 632 | ||
| Santosh Ramamurthy | 377 | 17 | 6 | 185 | 117 | 12 | 681 | |
| Michele Glinn | 195 | 55 | 2 | 252 | 76 | 15 | 649 | |
| Ramasri Sathanoori | 243 | 18 | 3 | 112 | 77 | 19 | 594 | |
| Dragoslava Živadinović | 349 | 45 | 3 | 106 | 184 | 20 | 726 | |
| Béatrice Georges | 238 | 56 | 2 | 143 | 81 | 24 | 690 | |
| Karla Hernández‐Fonseca | 288 | 15 | 7 | 269 | 139 | 17 | 695 | |
| Barbara Dziedzic | 192 | 7 | 12 | 91 | 78 | 19 | 541 | |
| Sandrine De Seranno | 239 | 36 | 179 | 158 | 10 | 676 |
All Works
Loading papers...